Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation

Y. Wang, T. Hayashi, C. F. Chang, Y. H. Chiang, L. I. Tsao, T. P. Su, C. Borlongan, S. Z. Lin

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

Background and Purpose - Previous studies have indicated that both methamphetamine (MA) and ischemia/reperfusion injuries involve reactive oxygen species formation and activation of apoptotic mechanism. That MA could have a synergistic or additive effect with stroke-induced brain damage is possible. The purpose of the present study was to investigate whether administration of MA in vivo would potentiate ischemic brain injury. Methods - Adult CD-1 mice were pretreated with MA or saline. Each animal later was anesthetized with chloral hydrate and placed in a stereotaxic frame. A subset of animals received intracerebral administration of glial cell line-derived neurotrophic factor (GDNF). The right middle cerebral artery and bilateral carotids were transiently occluded for 45 minutes. Regional cerebral blood flow was measured by laser Doppler. Animals were sacrificed for triphenyltetrazolium chloride staining and p53 mRNA Northern blot assay after 24 hours of reperfusion. Cortical and striatal GDNF levels were assayed by ELISA. Results - We found that pretreatment with MA increased ischemia-induced cerebral infarction. Ischemia or MA alone enhanced p53 mRNA expression. Moreover, MA potentiated expression of p53 mRNA in the ischemic mouse brain. MA pretreatment decreased GDNF levels in ischemic striatum. Intracerebral administration of GDNF before ischemia reduced MA-facilitated infarction. Conclusions - Our data indicate that MA exacerbates ischemic insults in brain, perhaps through the inhibition of GDNF-mediated pathways and suggest that MA may antagonize endogenous neuroprotective pathways as part of its mechanism of action.

Original languageEnglish
JournalStroke
Volume32
Issue number3
Publication statusPublished - 2001
Externally publishedYes

Fingerprint

Methamphetamine
Middle Cerebral Artery
Reperfusion
Ligation
Ischemia
Glial Cell Line-Derived Neurotrophic Factor
Messenger RNA
Cerebrovascular Circulation
Brain
Chloral Hydrate
Corpus Striatum
Cerebral Infarction
Regional Blood Flow
Reperfusion Injury
Northern Blotting
Brain Injuries
Infarction
Reactive Oxygen Species
Lasers
Enzyme-Linked Immunosorbent Assay

Keywords

  • Amphetamines
  • Apoptosis
  • Cerebral ischemia, focal
  • Transforming growth factors

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Neuroscience(all)

Cite this

Wang, Y., Hayashi, T., Chang, C. F., Chiang, Y. H., Tsao, L. I., Su, T. P., ... Lin, S. Z. (2001). Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. Stroke, 32(3).

Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. / Wang, Y.; Hayashi, T.; Chang, C. F.; Chiang, Y. H.; Tsao, L. I.; Su, T. P.; Borlongan, C.; Lin, S. Z.

In: Stroke, Vol. 32, No. 3, 2001.

Research output: Contribution to journalArticle

Wang, Y, Hayashi, T, Chang, CF, Chiang, YH, Tsao, LI, Su, TP, Borlongan, C & Lin, SZ 2001, 'Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation', Stroke, vol. 32, no. 3.
Wang, Y. ; Hayashi, T. ; Chang, C. F. ; Chiang, Y. H. ; Tsao, L. I. ; Su, T. P. ; Borlongan, C. ; Lin, S. Z. / Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation. In: Stroke. 2001 ; Vol. 32, No. 3.
@article{492e9de5754f4fdfb0c0df158e6387cc,
title = "Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation",
abstract = "Background and Purpose - Previous studies have indicated that both methamphetamine (MA) and ischemia/reperfusion injuries involve reactive oxygen species formation and activation of apoptotic mechanism. That MA could have a synergistic or additive effect with stroke-induced brain damage is possible. The purpose of the present study was to investigate whether administration of MA in vivo would potentiate ischemic brain injury. Methods - Adult CD-1 mice were pretreated with MA or saline. Each animal later was anesthetized with chloral hydrate and placed in a stereotaxic frame. A subset of animals received intracerebral administration of glial cell line-derived neurotrophic factor (GDNF). The right middle cerebral artery and bilateral carotids were transiently occluded for 45 minutes. Regional cerebral blood flow was measured by laser Doppler. Animals were sacrificed for triphenyltetrazolium chloride staining and p53 mRNA Northern blot assay after 24 hours of reperfusion. Cortical and striatal GDNF levels were assayed by ELISA. Results - We found that pretreatment with MA increased ischemia-induced cerebral infarction. Ischemia or MA alone enhanced p53 mRNA expression. Moreover, MA potentiated expression of p53 mRNA in the ischemic mouse brain. MA pretreatment decreased GDNF levels in ischemic striatum. Intracerebral administration of GDNF before ischemia reduced MA-facilitated infarction. Conclusions - Our data indicate that MA exacerbates ischemic insults in brain, perhaps through the inhibition of GDNF-mediated pathways and suggest that MA may antagonize endogenous neuroprotective pathways as part of its mechanism of action.",
keywords = "Amphetamines, Apoptosis, Cerebral ischemia, focal, Transforming growth factors",
author = "Y. Wang and T. Hayashi and Chang, {C. F.} and Chiang, {Y. H.} and Tsao, {L. I.} and Su, {T. P.} and C. Borlongan and Lin, {S. Z.}",
year = "2001",
language = "English",
volume = "32",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Methamphetamine potentiates ischemia/reperfusion insults after transient middle cerebral artery ligation

AU - Wang, Y.

AU - Hayashi, T.

AU - Chang, C. F.

AU - Chiang, Y. H.

AU - Tsao, L. I.

AU - Su, T. P.

AU - Borlongan, C.

AU - Lin, S. Z.

PY - 2001

Y1 - 2001

N2 - Background and Purpose - Previous studies have indicated that both methamphetamine (MA) and ischemia/reperfusion injuries involve reactive oxygen species formation and activation of apoptotic mechanism. That MA could have a synergistic or additive effect with stroke-induced brain damage is possible. The purpose of the present study was to investigate whether administration of MA in vivo would potentiate ischemic brain injury. Methods - Adult CD-1 mice were pretreated with MA or saline. Each animal later was anesthetized with chloral hydrate and placed in a stereotaxic frame. A subset of animals received intracerebral administration of glial cell line-derived neurotrophic factor (GDNF). The right middle cerebral artery and bilateral carotids were transiently occluded for 45 minutes. Regional cerebral blood flow was measured by laser Doppler. Animals were sacrificed for triphenyltetrazolium chloride staining and p53 mRNA Northern blot assay after 24 hours of reperfusion. Cortical and striatal GDNF levels were assayed by ELISA. Results - We found that pretreatment with MA increased ischemia-induced cerebral infarction. Ischemia or MA alone enhanced p53 mRNA expression. Moreover, MA potentiated expression of p53 mRNA in the ischemic mouse brain. MA pretreatment decreased GDNF levels in ischemic striatum. Intracerebral administration of GDNF before ischemia reduced MA-facilitated infarction. Conclusions - Our data indicate that MA exacerbates ischemic insults in brain, perhaps through the inhibition of GDNF-mediated pathways and suggest that MA may antagonize endogenous neuroprotective pathways as part of its mechanism of action.

AB - Background and Purpose - Previous studies have indicated that both methamphetamine (MA) and ischemia/reperfusion injuries involve reactive oxygen species formation and activation of apoptotic mechanism. That MA could have a synergistic or additive effect with stroke-induced brain damage is possible. The purpose of the present study was to investigate whether administration of MA in vivo would potentiate ischemic brain injury. Methods - Adult CD-1 mice were pretreated with MA or saline. Each animal later was anesthetized with chloral hydrate and placed in a stereotaxic frame. A subset of animals received intracerebral administration of glial cell line-derived neurotrophic factor (GDNF). The right middle cerebral artery and bilateral carotids were transiently occluded for 45 minutes. Regional cerebral blood flow was measured by laser Doppler. Animals were sacrificed for triphenyltetrazolium chloride staining and p53 mRNA Northern blot assay after 24 hours of reperfusion. Cortical and striatal GDNF levels were assayed by ELISA. Results - We found that pretreatment with MA increased ischemia-induced cerebral infarction. Ischemia or MA alone enhanced p53 mRNA expression. Moreover, MA potentiated expression of p53 mRNA in the ischemic mouse brain. MA pretreatment decreased GDNF levels in ischemic striatum. Intracerebral administration of GDNF before ischemia reduced MA-facilitated infarction. Conclusions - Our data indicate that MA exacerbates ischemic insults in brain, perhaps through the inhibition of GDNF-mediated pathways and suggest that MA may antagonize endogenous neuroprotective pathways as part of its mechanism of action.

KW - Amphetamines

KW - Apoptosis

KW - Cerebral ischemia, focal

KW - Transforming growth factors

UR - http://www.scopus.com/inward/record.url?scp=0034745249&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034745249&partnerID=8YFLogxK

M3 - Article

C2 - 11239201

AN - SCOPUS:0034745249

VL - 32

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 3

ER -